Literature DB >> 1739424

In vitro inhibition studies of the glucuronidation of 3'-azido-3'-deoxythymidine catalysed by human liver UDP-glucuronosyl transferase.

R Macleod1, V A Eagling, S M Sim, D J Back.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1739424     DOI： 10.1016/0006-2952(92)90303-z

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  3 in total

1.  Absence of effect of trimethoprim-sulfamethoxazole on pharmacokinetics of zidovudine in patients infected with human immunodeficiency virus.

Authors:  E Cañas; J Pachon; F Garcia-Pesquera; J R Castillo; P Viciana; J M Cisneros; M E Jimenez-Mejias
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

2.  Glucuronidation of 3'-azido-3'-deoxythymidine (zidovudine) by human liver microsomes: relevance to clinical pharmacokinetic interactions with atovaquone, fluconazole, methadone, and valproic acid.

Authors:  C B Trapnell; R W Klecker; C Jamis-Dow; J M Collins
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

3.  Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts.

Authors:  Eric Ouattara; Christine Danel; Raoul Moh; Delphine Gabillard; Gilles Peytavin; Romuald Konan; Jérome Le Carrou; Franck Bohoussou; Serge P Eholie; Xavier Anglaret
Journal:  J Int AIDS Soc       Date:  2013-04-30       Impact factor: 5.396
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.